中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
18期
137-139,152
,共4页
齐昆青%程团结%常红叶%陈小平%尚祥岭%徐璐璐%朴金龙%常杰
齊昆青%程糰結%常紅葉%陳小平%尚祥嶺%徐璐璐%樸金龍%常傑
제곤청%정단결%상홍협%진소평%상상령%서로로%박금룡%상걸
糖尿病前期%干预%糖尿病%患病率
糖尿病前期%榦預%糖尿病%患病率
당뇨병전기%간예%당뇨병%환병솔
Pre-diabetes%Intervention%Diabetes mellitus(DM)%Prevalence
目的:探讨生活干预联合药物控制延缓糖尿病前期发展为糖尿病的程度。方法对2011年6月某高校体检确诊为糖尿病前期200例职工进行观察,随机分为干预组(生活干预+药物控制)与对照组,观察期限为2年,比较两组患者1年后、2年后基础信息和糖尿病患病率。结果两组糖尿病前期职工干预前基础信息比较差异无统计学意义;观察组1年后糖尿病患病率为1%,对照组为13%,差异有统计学意义(x2=11.06,P<0.01);观察组2年后糖尿病患病率为2%,对照组为20%,差异有统计学意义(x2=11.06, P<0.01)。结论生活干预联合药物控制可能延缓糖尿病前期发展为糖尿病。
目的:探討生活榦預聯閤藥物控製延緩糖尿病前期髮展為糖尿病的程度。方法對2011年6月某高校體檢確診為糖尿病前期200例職工進行觀察,隨機分為榦預組(生活榦預+藥物控製)與對照組,觀察期限為2年,比較兩組患者1年後、2年後基礎信息和糖尿病患病率。結果兩組糖尿病前期職工榦預前基礎信息比較差異無統計學意義;觀察組1年後糖尿病患病率為1%,對照組為13%,差異有統計學意義(x2=11.06,P<0.01);觀察組2年後糖尿病患病率為2%,對照組為20%,差異有統計學意義(x2=11.06, P<0.01)。結論生活榦預聯閤藥物控製可能延緩糖尿病前期髮展為糖尿病。
목적:탐토생활간예연합약물공제연완당뇨병전기발전위당뇨병적정도。방법대2011년6월모고교체검학진위당뇨병전기200례직공진행관찰,수궤분위간예조(생활간예+약물공제)여대조조,관찰기한위2년,비교량조환자1년후、2년후기출신식화당뇨병환병솔。결과량조당뇨병전기직공간예전기출신식비교차이무통계학의의;관찰조1년후당뇨병환병솔위1%,대조조위13%,차이유통계학의의(x2=11.06,P<0.01);관찰조2년후당뇨병환병솔위2%,대조조위20%,차이유통계학의의(x2=11.06, P<0.01)。결론생활간예연합약물공제가능연완당뇨병전기발전위당뇨병。
Objective To investigate the role of the pre-diabetes intervention of college employees to diabetes mellitus. Methods 200 cases of college employee with pre-diabetes diagnosed at June 2011 were observed, who were randomly allocated to an intervention group(living intervention+pharmacological treatment) and a control group, which were observed for a period of two years. The basic information and diabetes prevalence after 1 year or 2 years in the two groups were compared. Results Differences of the basis information of employees with pre-diabetes between two groups were no statistically significant; one year later diabetes prevalence rate in the observation group was 1%, that in the control group was 13%, the difference was statistically significant (x2=11.06, P < 0.01); two years later diabetes prevalence rate in the observation group was 2%, which in the control group was 20%, the difference was statistically significant (x2=11.06, P < 0.01). Conclusion Living intervention and pharmacological treatment may delay the development of diabetes from pre-diabetes.